Skip to main content

Peer Review reports

From: The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development

Original Submission
10 Sep 2023 Submitted Original manuscript
2 Oct 2023 Reviewed Reviewer Report
3 Oct 2023 Reviewed Reviewer Report
2 Nov 2023 Author responded Author comments - Dipender Gill
Resubmission - Version 2
2 Nov 2023 Submitted Manuscript version 2
11 Nov 2023 Reviewed Reviewer Report
22 Nov 2023 Reviewed Reviewer Report
25 Nov 2023 Author responded Author comments - Dipender Gill
Resubmission - Version 3
25 Nov 2023 Submitted Manuscript version 3
9 Dec 2023 Author responded Author comments - Dipender Gill
Resubmission - Version 4
9 Dec 2023 Submitted Manuscript version 4
Publishing
12 Dec 2023 Editorially accepted
18 Dec 2023 Article published 10.1186/s12916-023-03227-5

You can find further information about peer review here.

Back to article page